跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SL NAD+ - TGA Drug Approval Details
Approvals
/
TGA
/
SL NAD+
Approved
STANDARD
SL NAD+
iX Biopharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
139df3307a94d151
Company
iX Biopharma Pty Ltd
Type
Standard
Approval Details
Approval Id
139df3307a94d151
Product Name
SL NAD+
Artg Id
451685
Artg Name
SL NAD+
Sponsor
iX Biopharma Pty Ltd
Company Detail Path
/organization/ix-biopharma-pty-ltd
Artg Date
2024-06-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
139df3307a94d151
Type
Standard
Back to TGA Approvals